ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO220

Oxalate Cardiotoxicity in CKD

Session Information

Category: Hypertension and CVD

  • 1601 Hypertension and CVD: Basic

Authors

  • Jaber, Karim, NYU Langone Health, New York, New York, United States
  • Xiong, Xiaozhong, NYU Langone Health, New York, New York, United States
  • Merritts, Kyle, NYU Langone Health, New York, New York, United States
  • Akosah, Yaw A., New York University College of Dentistry, New York, New York, United States
  • Pavlov, Evgeny, New York University College of Dentistry, New York, New York, United States
  • Nazzal, Lama, NYU Langone Health, New York, New York, United States
Background

Cardiovascular (CV) events are the leading cause of death among patients with chronic kidney disease (CKD), yet the underlying mechanisms remain poorly understood. Oxalate retention could significantly contribute to CVD in this population. Mitochondrial damage stands out as a potential mechanism of oxalate-induced toxicity, given its association with CKD-induced cardiac damage and oxalate nephrotoxicity.
We hypothesize that oxalate-enriched diet increases plasma oxalate levels, induces CV toxicity and mitochondria dysfunction.

Methods

H9C2 cardiomyocytes were cultured and treated with 0, 50, 100 and 250 uM of sodium oxalate (NaOx) for 48 hrs. Mitochondrial function was evaluated via the Seahorse assay, and mitochondrial morphology and membrane potential were assessed through staining.
12 5/6 nephrectomy (CKD) mice were administered either a 1% sodium oxalate supplemented normal chow (NC) or NC for three months. Plasma samples were collected for oxalate and creatinine measurements. Histology and mitochondrial imaging were performed on the heart tissue at sacrifice.

Results

In vitro studies demonstrated that sodium oxalate induces mitochondrial dysfunction in a dose-dependent matter.
Mice from both dietary groups showed a comparable degree of CKD at sacrifice but abnormal mitochondrial morphology was observed in the hearts of these oxalate fed mice, when compared to their controls.

Conclusion

Oxalate induces cardiotoxicity, possibly through mitochondrial damage.